Collapsing glomerulopathy associated with natural killer cell leukemia: A case report and review of the literature

American Journal of Kidney Diseases

Volumn 58, Issue 5, 2011, Pages 855-859

  Palma Diaz, Miguel F ^a   Pichler, Raimund H ^b   Nicosia, Roberto F ^a,c   Alpers, Charles E ^a   Smith, Kelly D ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

^c VA PUGET SOUND HEALTH CARE SYSTEM   (United States)

Author keywords

collapsing glomerulopathy; Focal segmental glomerulosclerosis; natural killer (NK) cell leukemia

Indexed keywords

CREATININE; CYCLOPHOSPHAMIDE; DEXAMETHASONE; ETOPOSIDE; INFUSION FLUID; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR; METHYLPREDNISOLONE; MITOXANTRONE; PREDNISONE; VINCRISTINE;

ADULT; AGGRESSIVE NK CELL LEUKEMIA; BONE MARROW BIOPSY; CASE REPORT; CELL DAMAGE; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CREATININE BLOOD LEVEL; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; DRUG MEGADOSE; EPSTEIN BARR VIRUS; ERYTHROPHAGOCYTOSIS; FOCAL GLOMERULOSCLEROSIS; FOLLOW UP; GLOMERULOPATHY; HUMAN; KIDNEY BIOPSY; LYMPHADENOPATHY; MALE; PODOCYTE; REVIEW; SPLENOMEGALY;

EID: 80054973503     PISSN: 02726386     EISSN: 15236838     Source Type: Journal    
DOI: 10.1053/j.ajkd.2011.07.011     Document Type: Article

References (25)

1. J.P. Greer, and C.A. Mosse Natural killer-cell neoplasms Curr Hematol Malig Rep 4 4 2009 245 252
2. V.D. D'Agati, A.B. Fogo, J.A. Bruijn, and J.C. Jennette Pathologic classification of focal segmental glomerulosclerosis: a working proposal Am J Kidney Dis 43 2 2004 368 382 (Pubitemid 38146337)
3. X. Liang, and D.K. Graham Natural killer cell neoplasms Cancer 112 7 2008 1425 1436 (Pubitemid 351441155)
4. M. Albaqumi, and L. Barisoni Current views on collapsing glomerulopathy J Am Soc Nephrol 19 7 2008 1276 1281
5. M. Albaqumi, T.J. Soos, L. Barisoni, and P.J. Nelson Collapsing glomerulopathy J Am Soc Nephrol 17 10 2006 2854 2863 (Pubitemid 44484675)
6. M. Haas Collapsing glomerulopathy: many means to a similar end Kidney Int 73 6 2008 669 671 (Pubitemid 351323254)
7. R.K. Detwiler, R.J. Falk, S.L. Hogan, and J.C. Jennette Collapsing glomerulopathy: a clinically and pathologically distinct variant of focal segmental glomerulosclerosis Kidney Int 45 5 1994 1416 1424 (Pubitemid 24135029)
8. M.A. Weiss, E. Daquioag, E.G. Margolin, and V.E. Pollak Nephrotic syndrome, progressive irreversible renal failure, and glomerular "collapse": a new clinicopathologic entity? Am J Kidney Dis 7 1 1986 20 28 (Pubitemid 16157415)
9. C.M. Wyatt, P.E. Klotman, and V.D. D'Agati HIV associated-nephropathy: clinical presentation, pathology, and epidemiology in the era of antiretroviral therapy Semin Nephrol 28 6 2008 513 522
10. S.J. Shankland, F. Eitner, K.L. Hudkins, T. Goodpaster, V. D'Agati, and C.E. Alpers Differential expression of cyclin-dependent kinase inhibitors in human glomerular disease: role in podocyte proliferation and maturation Kidney Int 58 2 2000 674 683 (Pubitemid 30620016)
11. M.B. Stokes, A.M. Valeri, G.S. Markowitz, and V.D. D'Agati Cellular focal segmental glomerulosclerosis: clinical and pathologic features Kidney Int 70 10 2006 1783 1792 (Pubitemid 44684810)
12. L. Barisoni, H.W. Schnaper, and J.B. Kopp A proposed taxonomy for the podocytopathies: a reassessment of the primary nephrotic diseases Clin J Am Soc Nephrol 2 3 2007 529 542
13. J.G. van den Berg, and J.J. Weening Role of the immune system in the pathogenesis of idiopathic nephrotic syndrome Clin Sci (Lond) 107 2 2004 125 136 (Pubitemid 39070928)
14. R.J. Shalhoub Pathogenesis of lipoid nephrosis: a disorder of T-cell function Lancet 2 7880 1974 556 560
15. G.S. Markowitz, S.H. Nasr, M.B. Stokes, and V.D. D'Agati Treatment with IFN-α, -β, or -γ is associated with collapsing focal segmental glomerulosclerosis Clin J Am Soc Nephrol 5 4 2010 607 615
16. O. Thaunat, M. Delahousse, and F. Fakhouri Nephrotic syndrome associated with hemophagocytic syndrome Kidney Int 69 10 2006 1892 1898 (Pubitemid 43739221)
17. A. Karras What nephrologists need to know about hemophagocytic syndrome Nat Rev Nephrol 5 6 2009 329 336
18. P.W. Mathieson Minimal change nephropathy and focal segmental glomerulosclerosis Semin Immunopathol 29 4 2007 415 426 (Pubitemid 350077265)
19. H. Pavenstadt, W. Kriz, and M. Kretzler Cell biology of the glomerular podocyte Physiol Rev 83 1 2003 253 307 (Pubitemid 36459882)
20. P.W. Mathieson Proteinuria and immunityan overstated relationship? N Engl J Med 359 23 2008 2492 2494
21. A.Y. Meyrier Treatment of focal segmental glomerulosclerosis with immunophilin modulation: when did we stop thinking about pathogenesis? Kidney Int 76 5 2009 487 491
22. C.A. Winkler, G. Nelson, T.K. Oleksyk, M.B. Nava, and J.B. Kopp Genetics of focal segmental glomerulosclerosis and human immunodeficiency virus-associated collapsing glomerulopathy: the role of MYH9 genetic variation Semin Nephrol 30 2 2010 111 125
23. G. Genovese, D.J. Friedman, and M.D. Ross Association of trypanolytic ApoL1 variants with kidney disease in African Americans Science 329 5993 2010 841 845
24. B.I. Freedman, J.B. Kopp, and C.D. Langefeld The apolipoprotein L1 (APOL1) gene and nondiabetic nephropathy in African Americans J Am Soc Nephrol 21 9 2010 1422 1426
25. G. Genovese, S.J. Tonna, and A.U. Knob A risk allele for focal segmental glomerulosclerosis in African Americans is located within a region containing APOL1 and MYH9 Kidney Int 78 7 2010 698 704